超声引导下微波消融治疗子宫肌瘤的临床疗效
|
摘要
目的分析子宫肌瘤行超声引导下微波消融治疗的临床疗效。方法 2014年2月—2017年11月,于该院收治的子宫肌瘤患者中选取100例,随机分为两组,对照组患者行射频消融术治疗,观察组患者行超声引导下微波消融治疗,对比两组治疗前后子宫肌瘤体积变化情况、临床疗效以及不良反应发生情况。结果观察组治疗总有效率为98.00%,对照组为96.00%,组间差异无统计学意义(P>0.05);两组治疗后子宫体积对比,组间差异无统计学意义(P>0.05);观察组治疗期间不良反应发生率为12.00%,低于对照组的40.00%,组间差异有统计学意义(χ~2=10.187 1,P<0.05)。结论子宫肌瘤行超声引导下微波消融治疗的临床疗效显著,与射频消融术相比,该手术方式的安全性更高,值得推广。
Objective To analyze the clinical efficacy of ultrasound-guided microwave ablation in uterine fibroids.Methods From February 2014 to November 2017, 100 patients with uterine fibroids admitted to our hospital were randomly divided into two groups. The control group were treated with radiofrequency ablation. The patients in the observation group underwent ultrasound-guided microwave ablation. Compare the changes of uterine fibroid volume before and after treatment, clinical efficacy and adverse reactions. Results The total effective rate was 98.00% in the observation group and 96.00% in the control group. There was no significant difference between the two groups(P>0.05). There was no significant difference in the uterus volume between the two groups after treatment(P>0.05). The incidence of adverse reactions during the period was 12.00%, which was lower than 40.00% in the control group. The difference between the groups was statistically significant(χ~2=10.1871, P<0.05). Conclusion The clinical efficacy of ultrasound-guided microwave ablation in uterine fibroids is significant. Compared with radiofrequency ablation, this procedure is safer and worthy of promotion.
Objective To analyze the clinical efficacy of ultrasound-guided microwave ablation in uterine fibroids.Methods From February 2014 to November 2017, 100 patients with uterine fibroids admitted to our hospital were randomly divided into two groups. The control group were treated with radiofrequency ablation. The patients in the observation group underwent ultrasound-guided microwave ablation. Compare the changes of uterine fibroid volume before and after treatment, clinical efficacy and adverse reactions. Results The total effective rate was 98.00% in the observation group and 96.00% in the control group. There was no significant difference between the two groups(P>0.05). There was no significant difference in the uterus volume between the two groups after treatment(P>0.05). The incidence of adverse reactions during the period was 12.00%, which was lower than 40.00% in the control group. The difference between the groups was statistically significant(χ~2=10.1871, P<0.05). Conclusion The clinical efficacy of ultrasound-guided microwave ablation in uterine fibroids is significant. Compared with radiofrequency ablation, this procedure is safer and worthy of promotion.
引文
[1]张英忠,王利娟,李少君,等.经腹超声引导聚桂醇联合射频消融术治疗子宫肌瘤的临床疗效及对患者血清E2、LH、FSH水平的影响[J].现代生物医学进展,2017,17(25):4936-4939.
[2]李秀梅,张晶,韩治宇,等.超声血流成像技术对子宫肌瘤经皮微波消融前能量的预测价值[J].中国超声医学杂志,2016,32(6):532-535.
[3]孙健,曾燕敏,陈军霞,等.超声引导下射频消融治疗子宫肌瘤临床价值研究[J].临床军医杂志,2017,45(7):664-667.
[4]戚云峰,董晓秋,张立维,等.超声引导下聚桂醇辅助射频消融术治疗子宫肌瘤的临床价值[J].中国超声医学杂志,2016,32(11):1022-1024.
[5]张立维,董晓秋,戚云峰,等.超声引导经阴道射频消融治疗症状性子宫肌瘤的临床价值[J].现代生物医学进展,2017,17(23):4471-4474.
[6]范融,薛华丹.MR引导下聚焦超声术治疗症状性子宫肌瘤的安全性及有效性[J].中华放射学杂志,2017,51(2):149-153.
[7]符忠祥,王伊,许永华.MRI引导和超声引导高强度聚焦超声完全消融子宫肌瘤比较研究[J].中国医学计算机成像杂志,2016,22(5):468-472.
[8]赵宁,董晓秋.子宫肌瘤血流情况和回声水平在超声引导下射频消融子宫肌瘤中的应用价值[J].临床超声医学杂志,2016,18(9):580-583.
[9]吕昌玉,张文翠.超声引导经皮微波消融治疗子宫肌瘤的临床应用效果观察[J].实用妇科内分泌杂志:电子版,2017,4(30):15-16.
[2]李秀梅,张晶,韩治宇,等.超声血流成像技术对子宫肌瘤经皮微波消融前能量的预测价值[J].中国超声医学杂志,2016,32(6):532-535.
[3]孙健,曾燕敏,陈军霞,等.超声引导下射频消融治疗子宫肌瘤临床价值研究[J].临床军医杂志,2017,45(7):664-667.
[4]戚云峰,董晓秋,张立维,等.超声引导下聚桂醇辅助射频消融术治疗子宫肌瘤的临床价值[J].中国超声医学杂志,2016,32(11):1022-1024.
[5]张立维,董晓秋,戚云峰,等.超声引导经阴道射频消融治疗症状性子宫肌瘤的临床价值[J].现代生物医学进展,2017,17(23):4471-4474.
[6]范融,薛华丹.MR引导下聚焦超声术治疗症状性子宫肌瘤的安全性及有效性[J].中华放射学杂志,2017,51(2):149-153.
[7]符忠祥,王伊,许永华.MRI引导和超声引导高强度聚焦超声完全消融子宫肌瘤比较研究[J].中国医学计算机成像杂志,2016,22(5):468-472.
[8]赵宁,董晓秋.子宫肌瘤血流情况和回声水平在超声引导下射频消融子宫肌瘤中的应用价值[J].临床超声医学杂志,2016,18(9):580-583.
[9]吕昌玉,张文翠.超声引导经皮微波消融治疗子宫肌瘤的临床应用效果观察[J].实用妇科内分泌杂志:电子版,2017,4(30):15-16.